BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20849407)

  • 1. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.
    Quillen K; Medrano C; Adams S; Peterson B; Hackett J; Leitman SF; Klein HG; Stroncek DF
    Transfusion; 2011 Mar; 51(3):504-10. PubMed ID: 20849407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
    Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
    Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
    Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
    Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of specificities of antibodies against human leukocyte antigens in blood donors.
    Endres RO; Kleinman SH; Carrick DM; Steele WR; Wright DJ; Norris PJ; Triulzi D; Kakaiya R; Busch MP;
    Transfusion; 2010 Aug; 50(8):1749-60. PubMed ID: 20158682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
    Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
    Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors.
    Fadeyi E; Adams S; Peterson B; Hackett J; Byrne P; Klein HG; Marincola FM; Leitman SF; Stroncek DF
    Transfusion; 2008 Jun; 48(6):1174-9. PubMed ID: 18422853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.
    Imoto S; Kawamura K; Tokumine Y; Araki N; Akita S; Nishimura C; Inaba H; Saigo K; Mabuchi O; Okazaki H
    Transfus Med; 2010 Apr; 20(2):95-103. PubMed ID: 19883399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
    Kleinman SH; Triulzi DJ; Murphy EL; Carey PM; Gottschall JL; Roback JD; Carrick D; Mathew S; Wright DJ; Cable R; Ness P; Gajic O; Hubmayr RD; Looney MR; Kakaiya RM;
    Transfusion; 2011 Oct; 51(10):2078-91. PubMed ID: 21446938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies.
    Fadeyi EA; Adams S; Sheldon S; Leitman SF; Wesley R; Klein HG; Stroncek DF
    Vox Sang; 2008 May; 94(4):324-8. PubMed ID: 18282262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors.
    Lopes LB; Fabron A; Chiba AK; Ruiz MO; Bordin JO
    Transfusion; 2010 Apr; 50(4):902-8. PubMed ID: 20003053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.
    Kakaiya RM; Triulzi DJ; Wright DJ; Steele WR; Kleinman SH; Busch MP; Norris PJ; Hillyer CD; Gottschall JL; Rios JA; Carey P; Glynn SA;
    Transfusion; 2010 Jun; 50(6):1328-34. PubMed ID: 20070615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
    Weisberg SP; Shaz BH; Tumer G; Silliman CC; Kelher MR; Cohn CS
    Transfusion; 2018 Apr; 58(4):891-895. PubMed ID: 29473178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
    Jug R; Anani W; Callum J
    Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
    van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
    Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.